ATE249475T1 - Oligonukleotid-analoge - Google Patents

Oligonukleotid-analoge

Info

Publication number
ATE249475T1
ATE249475T1 AT97905245T AT97905245T ATE249475T1 AT E249475 T1 ATE249475 T1 AT E249475T1 AT 97905245 T AT97905245 T AT 97905245T AT 97905245 T AT97905245 T AT 97905245T AT E249475 T1 ATE249475 T1 AT E249475T1
Authority
AT
Austria
Prior art keywords
attached
group
unsubstituted
cycloalkyl
alkenyl
Prior art date
Application number
AT97905245T
Other languages
English (en)
Inventor
Anthony David Baxter
Stephen Paul Collingwood
Mark Edward Douglas
Roger John Taylor
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE249475T1 publication Critical patent/ATE249475T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97905245T 1996-03-05 1997-02-24 Oligonukleotid-analoge ATE249475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9604669.3A GB9604669D0 (en) 1996-03-05 1996-03-05 Chemical compounds
PCT/GB1997/000499 WO1997032887A1 (en) 1996-03-05 1997-02-24 Oligonucleotide analogues

Publications (1)

Publication Number Publication Date
ATE249475T1 true ATE249475T1 (de) 2003-09-15

Family

ID=10789879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905245T ATE249475T1 (de) 1996-03-05 1997-02-24 Oligonukleotid-analoge

Country Status (12)

Country Link
US (1) US6562960B1 (de)
EP (1) EP0885237B1 (de)
JP (1) JP2000506849A (de)
CN (1) CN1212701A (de)
AT (1) ATE249475T1 (de)
AU (1) AU1886797A (de)
BR (1) BR9707918A (de)
CA (1) CA2247480A1 (de)
DE (1) DE69724768T2 (de)
GB (1) GB9604669D0 (de)
WO (1) WO1997032887A1 (de)
ZA (1) ZA971849B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639061B1 (en) 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
AU2002358464B2 (en) * 2001-12-18 2006-04-27 Human Genetic Signatures Pty Ltd Pseudonucleotide comprising an intercalator
FR2858976B1 (fr) * 2003-08-22 2006-02-10 Isochem Sa Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane
KR101654007B1 (ko) * 2007-08-15 2016-09-05 아이오니스 파마수티컬즈, 인코포레이티드 테트라하이드로피란 핵산 유사체
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
RU2612521C2 (ru) 2009-07-06 2017-03-09 Онтории, Инк. Новые пролекарства нуклеиновых кислот и способы их применения
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
CN103796657B (zh) 2011-07-19 2017-07-11 波涛生命科学有限公司 合成官能化核酸的方法
PL2872485T3 (pl) 2012-07-13 2021-05-31 Wave Life Sciences Ltd. Asymetryczna grupa pomocnicza
CA2879066C (en) 2012-07-13 2019-08-13 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
KR102213609B1 (ko) 2012-07-13 2021-02-08 웨이브 라이프 사이언시스 리미티드 키랄 제어
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4507433A (en) * 1983-10-07 1985-03-26 The Johns Hopkins University Preparation of oligodeoxyribonucleoside alkyl or arylphosphonates
US4806463A (en) 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (de) 1986-10-28 1990-09-19 The Johns Hopkins University Alkyl- oder Arylphosphonat-Oligonukleosid, das sich mit Nukleinesäuren vernetzen kann oder das Nukleinsäure spalten kann
GB8721442D0 (en) 1987-09-11 1987-10-21 Ciba Geigy Ag Process
JPH04501052A (ja) 1988-02-26 1992-02-27 ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ 外来性オリゴヌクレオチドによるｈｔｌｖ―３の抑制
DE69034150T2 (de) 1989-10-24 2005-08-25 Isis Pharmaceuticals, Inc., Carlsbad 2'-Modifizierte Oligonukleotide
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US6033909A (en) * 1992-01-22 2000-03-07 Hoechst Aktiengesellschaft Oligonucleotide analogs, their preparation and use
US5681747A (en) 1992-03-16 1997-10-28 Isis Pharmaceuticals, Inc. Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
US5625050A (en) * 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
GB9417746D0 (en) 1994-09-03 1994-10-19 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
CN1212701A (zh) 1999-03-31
US6562960B1 (en) 2003-05-13
CA2247480A1 (en) 1997-09-12
WO1997032887A1 (en) 1997-09-12
BR9707918A (pt) 1999-07-27
ZA971849B (en) 1997-09-05
EP0885237A1 (de) 1998-12-23
GB9604669D0 (en) 1996-05-01
EP0885237B1 (de) 2003-09-10
DE69724768T2 (de) 2004-08-05
DE69724768D1 (de) 2003-10-16
JP2000506849A (ja) 2000-06-06
AU1886797A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
ATE249475T1 (de) Oligonukleotid-analoge
HUP9701169A2 (hu) Cikloalkano-piridin-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
CO4560475A1 (es) Un producto de carbon modificado
ES2036551T3 (es) Compuestos heterociclicos.
DK0802188T3 (da) Heteroforbundne phenylglycinolamider som antiatherosklerotiske lægemidler
DE50001193D1 (de) Verfahren zur fermentativen herstellung von l-cystein oder l-cystein-derivaten
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
DE69615802D1 (de) Heterocyclische substituierte Benzofuran-Harnstoffe
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
IL119321A0 (en) Substituted milbemycin 5-oxime derivatives and pesticidal compositions containing the same
DE69328366D1 (de) Benzopyran und benzoxazin-derivate
ATE132139T1 (de) Diaminoethylen-verbindungen
DE60137437D1 (de) Promotoren zur proliferation und differenzierung von stammzellen und/oder vorstufen von neuronenzellen
AU2148595A (en) 4,6-di-t-butyl-2,3-dihydrobenzothiophene derivative
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
ATE328055T1 (de) Substituierte lineare thioureaverbindungen als schmiermittelzusatzstoff
MA24197A1 (fr) Nouvelles fungarrestines
WO1997047636A3 (en) Intermediates for oligonucleotide synthesis
AU4195893A (en) Alkylenediamine derivatives
KR840005711A (ko) N-치환-n-사이클로펜틸 글리신 유도체의 제조방법
FI903314A0 (fi) Foerfarande foer framstaellning av s-2,2-r1,r2-1,3-dioxolan-4-metanol.
ATE155785T1 (de) Mitomycinderivate
ES529415A0 (es) Procedimiento para la preparacion de derivados de piridin-pirimidinona

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties